Atossa Therapeutics, Inc. (ATOS) Dividend History

Atossa Therapeutics, Inc. (ATOS) is a biotechnology company focused on developing targeted treatments for breast cancer, hormone-related issues, and other serious medical conditions. The company is particularly known for its research into novel therapies involving breast health and hormone modulation, aiming to address unmet medical needs through innovative drug delivery methods and clinical development efforts.

10202 5th Avenue Ne, Seattle, WA, 98125
Phone: 206.588.0256
Website: https://www.atossatherapeutics.com

Dividend History

Atossa Therapeutics, Inc. currently does not pay dividends

Company News

  • Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit

    Atossa Therapeutics, a clinical-stage biopharmaceutical company, announced that its Vice President of Investor and Public Relations will participate in a virtual fireside chat at the 2024 Maxim Healthcare Virtual Summit.

    GlobeNewswire Inc.
  • Are Medical Stocks Lagging Alvotech (ALVO) This Year?

    Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.

    Zacks Investment Research
    Featured Companies: ALVO
  • Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst

    Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and a price target of $5.  Analysts Louise Chen, Carvey Leung, Wayne Wu, and Lucas Olson Duffy say that the peak sales potential of ATOS' pipeline is underappreciated.  Cantor notes that the company's lead program (Z)-endoxifen, is a promising new selective estrogen receptor modulator (SERM). According to published studies, (Z)-endoxifen is a competitive inhibitor of ERα and represses ERα transcriptional activity. ATOS' (Z)-endoxifen has been shown to be well ...Full story available on Benzinga.com

    Benzinga
  • Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week

    Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AMRX
  • Can Atossa Therapeutics Stock Keep Climbing?

    Investors want to know if this clinical-stage cancer drug developer can keep putting up big gains.

    The Motley Fool
Page data last updated 07/23/2025 17:01:35 UTC